K. Serfas

发表

Reports of information and support needs of daughters and sisters of women with breast cancer.

D. Tataryn, S. Scott-Findlay, S. Marles, 2003, European journal of cancer care.

DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.

W. Foulkes, P. Broderick, R. Houlston, 2011, JAMA.

Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers

Stephanie A Cohen, O. Olopade, B. Karlan, 2021, Breast Cancer Research and Treatment.

Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011.

Z. Cohen, E. Dicks, S. Holter, 2013, Current oncology.

APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.

A. Lagarde, M. Cappelli, K. Serfas, 2001, Gastroenterology.

Comparison of the Segregation of the RYR1 C1840T Mutation with Segregation of the Caffeine/Halothane Contracture Test Results for Malignant Hyperthermia Susceptibility in a Large Manitoba Mennonite Family

M. Phillips, D. Bose, C. Greenberg, 1996, Anesthesiology.

Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004–2019

K. McManus, M. Nachtigal, K. Decker, 2022, Current oncology.

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap

W. Meschino, H. Hirte, M. Bernardini, 2018, Journal of Medical Genetics.

Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk‐reducing surgical decision‐making practices: A mixed‐methods study

K. McManus, J. N. Hartley, M. Nachtigal, 2023, Journal of genetic counseling.

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

F. Couch, O. Olopade, P. Møller, 2023, Breast Cancer Research and Treatment.